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Summary
Dysfunctions of the ubiquitin proteasome system (UPS)
have been proposed to be involved in the aetiology
and ⁄or progression of several age-related neurodegener-
ative disorders. However, the mechanisms linking protea-
some dysfunction to cell degeneration are poorly
understood. We examined in young and aged rat hippo-
campus the activation of the unfolded protein response
(UPR) under cellular stress induced by proteasome inhibi-
tion. Lactacystin injection blocked proteasome activity in
young and aged animals in a similar extent and increased
the amount of ubiquitinated proteins. Young animals
activated the three UPR arms, IRE1a, ATF6a and PERK,
whereas aged rats failed to induce the IRE1a and ATF6a
pathways. In consequence, aged animals did not induce
the expression of pro-survival factors (chaperones, Bcl-XL
and Bcl-2), displayed a more sustained expression of pro-
apoptotic markers (CHOP, Bax, Bak and JKN), an increased
caspase-3 processing. At the cellular level, proteasome
inhibition induced neuronal damage in young and aged
animals as assayed using Fluorojade-B staining. However,
degenerating neurons were evident as soon as 24 h
postinjection in aged rats, but it was delayed up to 3 days
in young animals. Our findings show evidence supporting
age-related dysfunctions in the UPR activation as a
potential mechanism linking protein accumulation to cell
degeneration. An imbalance between pro-survival and
pro-apoptotic proteins, because of noncanonical activa-
tion of the UPR in aged rats, would increase the suscepti-
bility to cell degeneration. These findings add a new
molecular vision that might be relevant in the aetiology
of several age-related neurodegenerative disorders.
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inflammation; UPR.
Introduction
The proteasome is responsible for the majority of cellular proteo-
lysis by degrading multiple substrates that are important for
maintaining cellular viability (Pines and Lindon, 2005). In conse-
quence, proteasome dysfunctions could produce severe distur-
bances in cellular homeostasis, which should be restored by the
activation of specific cellular responses to assure cell viability.
Impairments in proteasome activity have been observed in
Alzheimer’s disease (AD) (Keller et al., 2000a; Lopez-Salon
et al., 2000; Keck et al., 2003) and in normal aging (Keller et al.,
2000b; Gavila´n et al., 2006). Indeed, paired helical filament-tau
from brains of patients with AD (Keck et al., 2003) or oligomeric
forms of the Ab peptide purified from a transgenic mouse model
of AD (Tseng et al., 2008) inhibited proteasome activity. In the
same way, we have previously shown that proteasome inhibi-
tion in rat hippocampus alters the endoplasmic reticulum (ER)
homeostasis, producing ER stress and inducing the UPR (Gavila´n
et al., 2006). This cellular response is mediated by the activation
of three signalling pathways (IRE1a, ATF6a and PERK) and is
characterized by the: (i) up-regulation of genes coding for differ-
ent molecular chaperones; (ii) attenuation of protein translation
and (iii) proteasomal degradation of misfolded proteins (Mori,
2000; Kaufman, 2002). However, whether ER stress persists,
cellular apoptosis is activated (Szegezdi et al., 2006).
In this line, ER stress has been proposed to mediate cellular
degeneration in a number of human diseases including AD
(Kaufman, 2002; Lindholm et al., 2006; Yoshida, 2007).
Similarly, disturbed activation of ER stress transducers has been
described in cell culture from mice model of familial AD-linked
Presenilin-1 mutations (Katayama et al., 2001), but data
from sporadic AD cases are still lacking. Nevertheless, the
mechanisms linking proteasome dysfunction, ER stress and cell
degeneration are currently poorly understood.
Taking into account that aging is the most relevant risk factor
to develop AD and that animal models of the sporadic variant
are lacking, it is essential to gain insight into how cells respond
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to cellular stress induced by protein accumulation in normal
aged brain, to better understand the pathophysiological states.
Therefore, we have evaluated at the molecular and cellular levels
in young and aged animals, the role of ER stress in mediating cell
degeneration, occasioned by protein accumulation induced by
proteasome inhibition. We have analysed the UPR activation
and found that aged animals did not induce efficiently it. The
inefficient UPR activation sensitized aged cells to ER stress
degeneration. Our data support that age-related dysfunctions in
UPR activation may represent a link between protein accumula-
tion and cell degeneration in aged animals. Present data could
contribute to understand the mechanisms underlying the higher
probability to develop AD during aging.
Results
UPR activation induced by lactacystin injection is
defective in aged rat hippocampus
To evaluate the UPR activation induced by proteasome inhibition
and the potential age-related modifications in young and aged
rat hippocampus, we performed a time-course analysis of the
three cellular pathways involved in the activation of the UPR
(IRE1a, ATF6a and PERK), following lactacystin injection.
As shown (Fig. 1A), lactacystin injection blocked chymotrypsin
activity in a similar extent in young and aged animals, producing
the accumulation of ubiquitinated proteins (Fig. 1B) that
induced ER stress (Gavila´n et al., 2006).
IRE1a pathway
IRE1a activation gives rise to an unconventional splicing of
the XBP1 mRNA through its C-terminal endonuclease domain
(Gonza´lez et al., 1999; Calfon et al., 2002), producing the
spliced form of XBP1 mRNA (sXBP1). This spliced mRNA is then
translated into a transcription factor that moves to the nucleus
activating the IRE1a pathway. As shown in Fig. 2A, lactacystin
injection significantly up-regulated (*P < 0.05) the mRNA
expression of the XBP1 gene in young but not in aged animals.
In the same way, the amount of sXBP1 mRNA significantly
increased from 6 to 14 h postinjection, only in young animals
(Fig. 2B). In consequence, young animals significantly increased
the amount of sXBP1 mRNA with respect to treated aged rats
(#P < 0.05). The nuclear amount of this transcription factor was
also evaluated, using proteins from the nuclear fraction of the
same young and aged animals. As shown in Fig. 2C,D, the
amount of processed (active) pXBP1 protein (Mr of 50 kDa)
remained unchanged in young animals from 6 to 14 h following
lactacystin injection, with respect to young control animals.
However, in aged animals the amount of pXBP1 protein signifi-
cantly decreased at 6 and 14 h postinjection (*P < 0.05), with
respect to aged controls, and also with respect to young treated
animals at 14 h postinjection (#P < 0.05). As also shown in
Fig. 2C, samples from aged rats showed a protein of Mr 30 kDa
(at 6 h postinjection) that, probably corresponded to the unpro-
cessed XBP1 (uXBP1) protein (Yoshida et al., 2006, 2009). This
protein, which is rapidly degraded by the proteasome (Tirosh
et al., 2006), is hardly detected by immunoblotting (Yoshida
et al., 2006) and acts as a negative regulator of the UPR activa-
tion (Lee et al., 2003; Yoshida et al., 2006; Tirosh et al., 2006;
Yoshida et al., 2009).
The IRE1a pathway is also linked to the c-Jun N-terminal
kinase (JNK) pathway through formation of an IRE1a–TRAF2–
ASK1 complex (Urano et al., 2000; Nishitoh et al., 2002). So,
we also analysed the activation of this pathway by western blots
(A) (B)
Fig. 1 Lactacystin injection blocks proteasome activity and induces protein accumulation in both young and aged hippocampus. (A) Proteasome activity was
assessed by quantification after the hydrolysis of a fluorogenic substrate specific for the chymotrypsin-like activity (LLVY-AMC), in samples from young and aged
lactacystin-treated rats (6 h postinjection). Data are presented as the mean ± SD relative to the activity of saline-injected animals. Data were obtained from
triplicate assays. A similar inhibition was observed in young and aged treated rats. (B) Ubiquitinated protein, predominantly those of higher molecular weight,
accumulated in young and aged rat hippocampus following lactacystin injection. Shown is a representative western blot corresponding to saline-injected animals
(young and aged), and lactacystin-injected rats (6 h postinjection). As previously described (Gavila´n et al., 2006), aged rats showed higher amount of
ubiquitinated proteins than young animals. *P < 0.05, significant differences compared to saline animals.
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using anti-phospho and total JNK antibodies, in young and aged
rats following proteasome inhibition. As shown in Fig. 2E, in
young animals the amount of phospho-JNK proteins remained
similar to saline-injected animals up to 14 h postlactacystin
injection, decreasing then from 24 to 72 h. By contrast, in aged
rats lactacystin injection produced a rapid and sustained phos-
phorylation of the JNK proteins (from 6 to 72 h). In conse-
quence, the phospho-JNK ⁄ total JNK ratio was significantly
increased with respect to saline-injected aged animals, and also
with respect to young animals (*, #P < 0.05) at all times post-
injection (Fig. 2F). These results suggest that proapoptotic
branch of the IRE1a pathway is active in aged animals. However
activation of JNK pathway may be due to other ER stress
independent stimuli (see Discussion).
ATF6a pathway
The mRNA expression of the ATF6a protein was analysed using
RT-real time PCR in the same group of young and aged animals.
ATF6a mRNA expression was significantly up-regulated
(*P < 0.05), with respect to saline-injected animals, in young
but no in aged rats (Fig. 3A), becoming significantly higher
(#P < 0.05) at 24 h postinjection in young with respect to aged
treated animals. Under ER stress conditions, full-length ATF6a
protein (90 kDa) is sequentially cleaved in the Golgi apparatus
using S1P and S2P proteases, to yield pATF650 (50 kDa) that
migrates into the nucleus. As shown in Fig. 3B,C, in our model
the amount of pATF650 protein significantly decreased
(*P < 0.05) in the nuclear fraction of both young and aged rats







Fig. 2 Molecular markers of the IRE1a pathway expressed in young and aged rat hippocampus following lactacystin injection. mRNA expression of total XBP1 (A)
and spliced XBP1 (B), analysed by RT-real time PCR, was up-regulated in young (n = 4 ⁄ time point), but not in aged rat hippocampus (n = 4 ⁄ time point) following
lactacystin injection. (C) Western blot of the XBP1 protein in the nuclear fraction of the same young and aged rats. The band of Mr 50 kDa, (pXBP1) corresponded
to the processed active transcription factor. The band of Mr 30 kDa corresponded to the un-processed (uXBP1) protein and was exclusively observed in aged
animals from 6 to 14 h postlactacystin injection. (D) Optical density analysis of western blots. Data are presented as mean ± SD of four independent experiments,
each one including one young and one aged animal at different times postlactacystin injection. (E) Western blot analysis of the phospho-JNK (upper panel) and
total-JNK (lower panel) expressed in young and aged rats following lactacystin injection. (F) Optical density analysis of western blots. Data are presented as
mean ± SD of four independent experiments, each one including one young and one aged animal at different times postlactacysitn injection. *P < 0.05,
significant differences compared to saline animals. #P < 0.05, significant differences between young and aged animals.
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recovered the basal level whereas in aged rats remained signifi-
cantly lower (*P < 0.05). This transcription factor mainly regu-
lates the expression of proteins involved in the ER protein
folding, such as molecular chaperones (Yoshida et al., 2000;
Ma et al., 2002; Yoshida, 2007). So, we analysed the mRNA
expression of several ER chaperones. As shown in Fig. 3D, the
mRNA expression of GRP78, PDI, Erp57 and P58IPK was signi-
ficantly up-regulated (*P < 0.05) in young animals from 6 to
24 h postinjection with respect to young control animals. By
contrast, in aged rats only the mRNA expression of GRP78 was
moderately but significantly up-regulated (*P < 0.05) just at
24 h postinjection (Fig. 3D). As a result the mRNAs of ER chaper-
ones were significantly up-regulated (#P < 0.05) in young with
respect to aged animals. In the same way, protein expression of
GRP78 remained unchanged in aged but not in young animals
(insert in Fig. 3D, see also Gavila´n et al., 2006). This effect
appeared to be more specific for the ER chaperones because the
mRNA expression of Hsp70 (a cytoplasmic chaperone) was
significantly up-regulated in both, young and aged rats from 14
to 24 h following lactacystin injection (data not shown).
PERK pathway
PERK activation produces the phosphorylation of the a subunit
of the eukaryotic translation initiation factor-2 (eIF2a) thus,
attenuating global protein synthesis (Novoa et al., 2001). So, we
analysed in young and aged treated animals the eIF2a phos-
phorylation level as a marker of the PERK pathway activation. As
shown in Fig. 4A,B, lactacystin injection significantly increased
(*P < 0.05) the phospho-eIF2a ⁄ total eIF2a ratio, in young and
aged rats, as soon as 6 h postinjection. In young animals, the
increase in the phospho-eIF2a ⁄ total eIF2a ratio was followed by
a significant decrease at 14 h (*P < 0.05), to finally reach the
basal level from 24 to 72 h. On the contrary, aged rats returned
to basal level from 14 to 72 h, but in a gradual manner. Impor-
tantly, the abrupt decrease in p-eIF2a, observed in young
animals 14 h after injection was totally lost in aged rats. This
age-related difference could be consequence of the lower
mRNA expression of the gene coding for the GADD34 protein in
aged respect to young animals (Fig. 4C). GADD34 is an UPR-
induced gene that encodes a b-subunit of the protein phospha-
tase 1 involved in eIF2a dephosphorylation (Novoa et al., 2001).
mRNA up-regulation of GADD34 was sustained from 6 to 24 h
postinjection in young and aged animals but with different
intensity (in average, ten and fourfolds of increase respect to
saline animals for young and aged rats respectively).
Phosphorylation of eIF2a leads to a transient suppression of
general translation, but increases translation of the mRNA for
ATF4 as a consequence of a ribosome-scanning mechanism and
two short upstream open reading frames in the ATF4 mRNA
(Lu et al., 2004; Vattem & Wek, 2004). As shown in Fig. 4D, in
(A) (B)
(C) (D)
Fig. 3 Molecular markers of the ATF6a pathway expressed in young and aged rat hippocampus following lactacystin injection. (A) mRNA expression of ATF6a
was up-regulated in young but not in aged rat hippocampus following lactacystin injection. (B) Representative western blot of the active transcription factor
pATF650 in the nuclear fraction of young and aged rats. (C) Optical density from western blots. Data are presented as the mean ± SD of four independent
experiments, each one including one young and one aged animal at different times postlactacystin injection. (D) mRNA expression of the ER chaperones GRP78,
PDI, Erp57 and P58IPK following lactacystin injection in young and aged rats. All the mRNAs analysed were significantly up-regulated in young animals in a time-
dependent manner. In aged rats, only the GRP78 mRNA was significantly up-regulated at 24 h postinjection. In the insert is shown a representative western blot of
the GRP78 protein expressed in young and aged animals at 14 and 24 h postinjection (samples for four animals were pooled per time point; see also Gavila´n et al.,
2006). *P < 0.05, significant differences compared to young or aged saline animals. #P < 0.05, significant differences between young and aged animals.
UPR dysfunction in aged hippocampus, Marı´a Paz Gavila´n et al.
ª 2009 The Authors
Journal compilation ª Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2009
657
contrast to the transcription factors pXBP1 and pATF6(50), ATF4
protein was significantly increased (*P < 0.05) in the nuclear
fraction of young animals from 6 to 14 h postinjection. In aged
rats, ATF4 protein also tended to increase during the first 24 h,
reaching a significant increase, at 3 days postinjection, with
respect to both, saline-injected animals and young rats
(#,*P < 0.05). Interestingly, the increased translation of ATF4
leads to induction of ATF4-responsive genes involved in the ER
stress response, such as the pro-apoptotic transcription factor
CHOP. As CHOP needs to be translocated and accumulated into
the nucleus to induce apoptosis (Zinszner et al., 1998), we next
analysed the expression of CHOP protein in nuclear fractions of
young and aged treated rats. As shown in Fig. 4F, CHOP protein
was clearly detected at 24 h postinjection in the nuclear fraction
of both young and aged animals. However, at 72 h postinjection
the nuclear content of CHOP was imperceptible, in young, but
remained high in aged animals.
Altogether, these results strongly support that lactacystin-
induced ER stress produced a canonical UPR activation
(IRE1a-XBP1, ATF6a and PERK-eIF2a signalling pathways) in
young animals, whereas in aged rats the IRE1a-XBP1 and ATF6a
pathways were not efficiently activated.
The pro-apoptotic proteins Bax a Bak and the pro-
survival proteins Bcl-XL and Bcl-2 are differentially
expressed in young and aged lactacystin-treated rats
The UPR includes pro-survival and pro-apoptotic pathways (Rut-
kowski & Kaufman, 2007; Yoshida, 2007). As aged rats did not
efficiently induce the UPR, we examined whether this age-
related dysfunction affected the balance between UPR-induced
pro-apoptotic and pro-survival proteins. For that, we analysed
the expression of two pro-apoptotic and two pro-survival pro-
teins of the Bcl-2 family related to ER stress (Rudner et al., 2002;
Thomenius et al., 2003; Hetz et al., 2006). As shown in
Fig. 5A,B, the expression profile of pro-apoptotic proteins Bax
an Bak in young rats was the opposite of that observed for aged
animals. Whereas the expression of these two pro-apoptotic
proteins was significantly decreased in young animals
(*P < 0.05) they were significantly increased in aged animals
(#,*P < 0.05). By contrast, the expression of the pro-survival
proteins Bcl-2 (*P < 0.05) and Bcl-XL (#,*P < 0.05) was signifi-
cantly increased in young rats, but decreased in aged animals
(Fig. 5C,D). Thus, these findings demonstrate the existence of
an age-related imbalance between anti- and pro-apoptotic
(A) (B) (C)
(D) (E) (F)
Fig. 4 Molecular markers of the PERK pathway expressed in young and aged rat hippocampus following lactacystin injection. (A) Representative western blot of
the phospho-eIF2a (P-eIF2a) and total eIF2a proteins expressed in the cytosolic fraction of young and aged rat hippocampus following lactacystin injection.
Membranes were first incubated with a specific antibody against P-eIF2a, and then incubated with a second specific antibody against total eIF2a. (B) Optical
density analysis of western blots. Shown is the P-eIF2a ⁄ eIF2a ratio. Data are represented as mean ± SD of four independent experiments, each one including one
young and one aged animal at different times postlactacystin injection. The P-eIF2a ⁄ eIF2a ratio was significantly increased in young and aged animals at 6 h
postinjection and rapidly decreased in young but not in aged rats at 14 h postinjection. (C) mRNA expression of GADD34 was significantly up-regulated in young
an aged animals following lactacystin injection. (D) Representative western blot corresponding to the transcription factor ATF4 in the nuclear fraction of young and
aged animals following lactacystin injection. (E) Optical density analysis of western blots. Data are presented as mean ± SD of four independent experiments, each
one including one young and one aged animal at different times postlactacystin injection. ATF4 protein was significantly increased in the nuclear fraction of young
animals from 6 to 14 h and significantly decreased at 72 h. Aged rats also tended to increase the nuclear content of ATF4 during the first 24 h, however a
significant increase was noted at 72 h. (F) Representative western blot corresponding to the transcription factor CHOP. The pro-apoptotic factor CHOP was
exclusively observed in the nuclear fraction at 24 h after lactacystin injection in young rats. In aged rats, CHOP expression was also first detected at 24 h but was
sustained up to 72 h. The experiment was done twice with similar results. Beta-actin corresponded to aged samples. Not differences with respect to young b-actin
samples were observed (not shown). *P < 0.05, significant differences compared to saline animals. #P < 0.05, significant differences between young and aged
animals.
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proteins, following lactacystin injection, resulting in a prolonged
expression of pro-apoptotic markers in aged rat hippocampus.
Lactacystin injection increased neurodegeneration
and caspase-3 processing in aged with respect to
young rats
We also analysed at the cellular level whether lactacystin injec-
tion induced cellular degeneration. Coronal sections of a new
population of young (n = 6) and aged (n = 6) lactacystin-
treated animals (24 h and 3 days postinjection) was stained with
Fluorojade-B. As shown in Fig. 6, saline-injected animals did not
show Fluorojade-B stained cells (A1-B1 and A2-B2, for young
and aged rats respectively). At 24 h postinjection, young animals
showed a few Fluorojade-B positive cells located near the trace
of injection (CA1 region). However, aged rats showed a qualita-
tive increase in the number and intensity of Fluorojade-B positive
cells. Positive neurons were not exclusively located near the
(A) (B)
(C) (D)
Fig. 5 Pro-apoptotic and pro-survival proteins expressed in young and aged rat hippocampus following lactacystin injection. Representative western-blots and
densitometric analysis of pro-apoptotic proteins Bax (A) and Bak (B) and the anti-apoptotic proteins Bcl-XL (C) and Bcl-2 (D). In aged rats, the pro-apoptotic
proteins Bax and Bak were significantly increased from 24 to 72 h, and from 6 to 72 h respectively. Young animals did not modify or even decreased the
expression of these two pro-apoptotic proteins. On the contrary, young animals displayed and increase in the expression of the pro-survival proteins Bcl-XL (from
14 to 72 h pos-lactacystin injection), and Bcl-2 (14 h), whereas aged rats did not modify, or even decreased, the expression of these two pro-survival proteins.
Interestingly, Bcl-XL was significantly decreased at 6 h postinjection. *P < 0.05, significant differences compared to saline animals. #P < 0.05, significant
differences between young and aged animals.
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trace of injection, but also in the pyramidal and granular layer of
the CA3 and dentate gyrus respectively. Interestingly, in young
rats after 3 days postinjection, the neurodegeneration spreads
progressively from injection zone (CA1) to the whole hippocam-
pal formation (CA3, dentate gyrus and hilar region) in both,
young and aged animals. However, aged rats showed an evi-
dent increase in the number and intensity of Fluorojade-B posi-
tive cells, respect to young animals, mostly at the CA3 and
granular layer (Fig. 6 G2-H2 and F2-I2, for young and aged rats
respectively). The putative cell degeneration revealed using Flu-
orojade-B staining was further confirmed by cresyl violet stain-
ing. As shown in Fig. 7, aged rats showed a clear qualitative
difference in the amount of cresyl violet stained neurons mostly
in the CA3 region, with respect to both, aged saline-injected
(compare a2 with b2) and young lactacystin-treated rats (com-
pare b2 with b1). Currently, the reasons for this apparent higher
sensitivity of the CA3 neurons to lactacystin injection remain to
be analysed.
Finally, we evaluated whether higher neurodegeneration
observed in lactacystin-treated aged rats was also reflected in a
higher processing of the executioner caspase-3. As shown in
Fig. 7B, procaspase-3 processing was strongly increased in aged
with respect to young treated animals at both, 24 and 72 h,
whereas in young animals a modest increase was observed just
at 72 h postinjection.
Discussion
The overall aim of the present work was to identify potential
mechanisms linking age-dependent neuronal vulnerability and
protein accumulation. For that, we have examined the UPR acti-
vation in young and aged rat hippocampus following protea-
some inhibition as a potential factor. This issue is of special
relevance considering that impairments in the proteasome-med-
iated degradation pathway have been propose to contribute to
the development of several age-related neurodegenerative
disorders including AD (Keller et al., 2000a; Keck et al., 2003;
Katayama et al., 2004; Cecarini et al., 2007). However, the
mechanisms underlying cell degeneration caused by protein
accumulation are still elusive. The most relevant finding shown
in this work is the existence of age-related deficits in the
UPR activation following proteasome inhibition that could
(A1) (B1) (A2) (B2)
(C1) (D1) (C2) (D2)
(G1) (F1) (G2) (F2)
(H1) (I1) (H2) (I2)
Fig. 6 Higher susceptibility to neurodegeneration in aged rats following lactacystin injection. Cellular degeneration was analysed by Fluorojade-B staining in brain
sections from young and aged lactacystin-treated rats. Analysis was performed at 24 h (A1–I1) and 3 days postinjection (A2–I2). (C1, G1, H1) After 24 h,
lactacystin injection did not induce cellular degeneration in young rat hippocampus (n = 3, 6 sections ⁄ animal) and only a moderate staining for Fluorojade-B was
only observed at the injection track (CA1 region, asterisk). (D1, F1, I1) Aged animals showed Fluorojade-B positive neurons at the injection track (CA1 region,
asterisk), and also in the CA3 region and granular layer of the dentate gyrus (distal from the injection site) (n = 3, 6 sections ⁄ animal). (C2, G2, H2) At 3 days
postinjection, in young animals the number of Fluorojade-B positive neurons progressed from CA1 to CA3 and the hilar region of dentate gyrus. (D2, F2, I2) Aged
rats displayed a similar pattern of cellular degeneration as observed for young rats, but qualitatively, a higher number and more intensity of Fluorojade-B positive
neurons were observed in aged rats, predominantly in the CA3 and dentate gyrus regions.
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compromise cell viability. We report novel data potentially rele-
vant to cell apoptosis induced by ER-stress that are summarized
as follows. (i) Lactacystin injection induced a canonical UPR
activation in young rats, but an inefficient UPR activation in aged
rats. (ii) Following lactacystin injection, young animals predo-
minantly and early expressed pro-survival factors, whereas in
aged rats were mainly induced pro-apoptotic factors. (iii)
Neurodegeneration induced using lactacystin injection was
earlier observed in aged animals.
UPR activation in young and aged rat hippocampus
Following lactacystin injection, young rats induced an early and
simultaneous activation of the three UPR pathways. The sXBP1
and ATF6a mRNAs, in addition to the phosphorylation of eIF2a,
were quickly increased. However, the protein level of these tran-
scription factors, pXBP1 and pATF650, were not altered in the
nuclear fractions. The reasons for this apparent discrepancy are
actually unknown. One potential explanation could be attribut-
able to the PERK-dependent protein translation attenuation
occurring during UPR (Harding et al., 2000, 2002; Novoa et al.,
2001; DeGracia et al., 2002). In this line, in vitro experiments
estimated that, 6 h after induction of ER stress, translation rep-
resent 38%, respect to baseline levels (Marciniak et al., 2004).
So, as we observed in this work, at the earliest phase of UPR acti-
vation the increase in the mRNA expression could produce no
variation (or even decrease) at the protein level. This speculation
is supported by the fact that the transcription factor ATF4, which
escapes from protein translation inhibition during UPR activation
(Lu et al., 2004; Vattem & Wek, 2004), was the only transcrip-
tion factor increased at 6 h postinjection. In any case, we are
aware that comprehension of the UPR regulation is a very com-
plex process that probably depends on the stressor stimulus and
escape from the main goal of the present work.
Independently of the molecular mechanisms, our data
clearly demonstrated that transcriptional activation of the
UPR is occurring in young rats following lactacystin injection.





Fig. 7 Cresyl violet staining and caspase-3 processing in young and aged rat hippocampus following lactacystin injection. (A) Representative coronal sections
from young: saline (a1) and 3 days postlactacystin injection (b1); and aged: saline (a2) and 3 days postlactacystin injection (b2), stained with cresyl violet. Cresyl
violet positive neurons were qualitatively decreased in young and aged rats at 3 days following lactacystin injection respect to saline-injected animals. Importantly
aged rats showed a more extensive loss of cresyl violet staining than young animals in the CA3 region (arrows). (B) Representative western blot analysis showing
procaspase-3 (30 kDa) and the processed fragments (17–19 kDa) at 24 and 72 h postlactacystin injection in young and aged animals. Active fragments were
evident in aged animals from 24 to 72 h postlactacystin injection, whereas in young animals, the processed fragments were barely detected. Both, pro-caspase
and processed fragments corresponded to the same gel. To a better visualization, the portion corresponding to the processed fragments were overexposed.
Shown is also the optical density analysis of western blots. Data are presented as mean of two independent experiments, each one including young and aged
animals at different times postlactacystin injection (four animals pooled ⁄ time point ⁄ group).
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(preceding its processing), ATF6a mRNA, and also molecular
chaperones (such as, GRP78, PDI, Erp57 and P58IPK), well-
known downstream markers of the IRE1a and ATF6a path-
ways. However, none of these events were observed in aged
lactacystin-treated rats. By contrast, the PERK-ATF4 pathway
was also activated in aged rats. These findings support the
notion that the ATF6a and IRE1a pathways are interactive,
while the PERK pathway could be relatively independent
(Yoshida et al., 2001, 2009). Despite PERK-ATF4 pathway
was activated in aged rats, a potential relevant data was
that release of protein translation inhibition was more pro-
nounced in young than in aged animals (Fig. 4B, 14 and
24 h). This fact suggests that the more persistent translation
arrest that takes place in aged could be detrimental to cell
viability (see DeGracia et al., 2002 for a detailed review).
In this sense, the UPR activation observed in young rats
was concomitant with an early predominant expression of
prosurvival proteins, low caspase-3 processing and moderate
hippocampal neurodegeneration. Indeed, degenerating neu-
rons were evident only at 3 days postlactacystin injection,
and in a lower extension than in aged rats. Particularly, from
24 to 72 h young animals displayed a low activation of JNK
pathway, expressed low levels of Bax and Bak proteins, and
transitorily expressed the UPR related pro-apoptotic factor
CHOP in the nuclear fraction. On the other hand, chaper-
ones (see also Gavila´n et al., 2006) and the anti-apoptotic
protein Bcl-XL and Bcl-2 were up-regulated. By contrast, a
different scenario was observed in aged rats. During the
same postinjection period (24–72 h), aged animals showed a
higher activation of the JNK pathway, higher levels of pro-
apoptotic proteins Bax and Bak and a sustained expression
of the pro-apoptotic factor CHOP in the nuclear fraction.
Chaperones (see also Gavila´n et al., 2006) and the anti-
apoptotic proteins were decreased or not modified. Accord-
ingly, aged rats displayed higher caspase-3 processing, and
an earlier (24 h) and higher hippocampal neurodegeneration.
A similar activation of JNK pathway and high CHOP expres-
sion has been previously observed in old, with respect to
young hepatocytes, under ER stress induced using two differ-
ent stressors: thapsigargin and tunicamycin (Nikki & Hol-
brook, 2004). We are aware that activation of the JNK
pathway it is not exclusively linked to IRE1a activation, but
also to other signalling pathways such as initiated by Fas–
FasL interaction, or TNF receptors activation, which cannot
be discarded to be activated in this model.
Finally, at the present, the molecular mechanisms underly-
ing the UPR dysfunction in aged animals are unknown.
Based on our findings, we can propose that uXBP1 protein,
observed exclusively in aged rats, might be acting as a domi-
nant-negative inhibitor of pXBP1 (IRE1a pathway) and
pATF650 (ATF6a pathway). As previously reported (Yoshida
et al., 2006, 2009), uXBP1 can move between the nucleus
and the cytoplasm (because of the presence of a nuclear
exclusion signal in the C-terminal region of uXBP1; absent in
pXBP1). This uXBP1 protein attenuates the UPR activation by
association with pXBP1 (Yoshida et al., 2006) and pATF650,
but not with ATF4 (Yoshida et al., 2009), sequestering them
from the nucleus and increasing proteasomal-dependent
degradation of these complexes (Tirosh et al., 2006). Impor-
tantly, overexpression of uXBP1 protein prevents an effective
UPR activation and favours apoptosis in tumoral cells in
response to proteasome inhibition (Lee et al., 2003). Also,
survival of tumoral cells seems to be related with the
sXBP1 ⁄ uXBP1 mRNA ratio (Davies et al., 2008). In conse-
quence, understanding the physiological causes of uXBP1
accumulation in aged cells may have a potential interest at
the therapeutic level. However, we cannot discard other cur-
rently unknown mechanisms that could account for the inef-
ficient UPR activation in aged animals.
Taken together, these data strongly suggest that an inefficient
UPR activation could be a molecular link between cellular degen-
eration and protein accumulation due to proteasome dysfunc-
tion, which could contribute to explain why aging constitutes
the major risk factor to develop degenerative diseases. More-
over, present work adds new data supporting that UPR dysfunc-
tion seems to play a role in determining cell viability under
different stress conditions in aging (Naidoo et al., 2008), making
it attractive as therapeutic target. Further investigation will be
necessary to look for similar age-related deficits in AD for which
proteasome dysfunction has been described (Keller et al.,




Young (3–4 months, 250-350 g) and aged (24–26 months,
650-750 g) male Wistar rats were provided by the animal care
facility from the University of Seville. Animals were housed in
either static or ventilated microisolator cages on bedding. Bed-
ding, cages and drinking bottles were always autoclaved. Water
supply was sterilized and commercial food was pasteurized.
Periodically, samples of animals were subjected to complete
serological, microbiological and endo- and ecto-parasitic evalua-
tion. All animal experiments were carried out in accordance with
the Guidelines of the European Union Council (86 ⁄ 609 ⁄ EU), fol-
lowing the Spanish regulations (BOE 252 ⁄ 34367-91, 2005) for
the use of laboratory animals and approved by the correspond-
ing Scientific Committee of the University of Seville. All efforts
were made to minimize the number of animals used and their
suffering.
Surgery
Young male Wistar rats (n = 38) and aged male Wistar rats
(n = 38) were used for surgery. Animals were anaesthetized
with 400 mg kg)1 chloral hydrate and positioned in a stereo-
taxic apparatus (Kopf Instruments, Tujunga, CA, USA) to
conform to the rat brain atlas (Paxinos & Watson, 1986).
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Lactacystin (Sigma-Aldrich, St Louis, MO, USA) was dissolved
(10 mg mL)1) in a solution of sterilized phosphate-buffered
saline (PBS) and 1 lL was injected into both hippocampi.
Coordinates for young animals were: 4.5 mm posterior,
± 3.6 mm lateral and 3.6 mm ventral to the bregma and for
aged rats were: 6.0 mm posterior, ± 4.6 mm lateral and
4.6 mm ventral to the bregma. To decide the coordinates
for aged animals, four additional animals were previously
injected with an inert tracer (monastral blue) at different
coordinates according to Paxinos & Watson (1986). Injections
were delivered over a period of 2 min each after which, the
needle was left in situ for an additional 5 min to avoid reflux
along the injection track. Animals were decapitated at 6, 14,
24 and 72 h (n = 4 per time point) after lactacystin injection
and brains were quickly removed. Control animals (n = 3
per time point) were processed similarly but received in both
hippocampi an intrahippocampal injection (1 lL each) of
sterilized PBS (saline-injected animals). LPS injection
(2.5 lg ⁄ hippocampus) was performed exactly as previously
described (Gavila´n et al., 2009).
RNA extraction and reverse transcription
For PCR analysis, young and aged rats were previously anaesthe-
tized as previously described and killed by decapitation. Both
hippocampi (150–160 mg wet weight) were dissected, frozen in
liquid N2 and stored at )80 C until use. Total RNA was
extracted using the TripureTM Isolation Reagent (Roche,
Mannheim, Germany), according to the instructions of the man-
ufacturer. The recovery of RNA was similar between young and
aged animals (ranging from 1.2 to 1.4 lg mg)1 of tissue).
Reverse transcription was performed using random hexamers
primers exactly as previously described (Gavila´n et al., 2006,
2009).
Real-time PCR
cDNAs were diluted in sterile water and used as template for the
amplification by the polymerase chain reaction. Optimization
and amplification of each specific gene product was performed
using the ABI Prism 7000 sequence detector (Applied Biosys-
tems, Madrid, Spain) and Sybr greenTM, as previously described
(Gavila´n et al., 2006, 2009). Primers were designed using the
PROBEFINDER softwareTM (Roche Applied Science) and are listed in
Table 1. All of them flanked an intronic sequence to ensure the
absence of genomic contamination. The cDNA levels of the dif-
ferent animals were determined using two different housekeep-
ers (GAPDH and b-actin). The amplification of the housekeepers
was done in parallel with the gene to be analysed. Similar results
were obtained using both housekeepers. Thus, the results were
normalized using only the b-actin expression. Threshold cycle
(Ct) values were calculated using the software supplied by
Applied Biosystems.
Subcellular fractionation
Young and aged rat hippocampi were homogenized in 500 lL
of ice cold sucrose buffer (0.25 M sucrose, 1 mM EDTA, 10 mM
Tris–HCl, pH 7.4), supplemented with protease inhibitor cocktail
(Sigma). Aliquots of 150 lL were separated to RNA purification
as previously described. The nuclear and the cytosolic fractions
were separated by sequential centrifugation steps exactly as pre-
viously described (Gavila´n et al., 2009). The purity of both frac-
tions was tested by western blot using the neuron-specific
nuclear protein specific antibody, NeuN (neuronal nuclei; data
not shown, see Gavila´n et al., 2009). Protein concentration was
determined for each fraction using bovine albumin as standard
(Lowry et al., 1951).
Immunoblots
Immunoblots were done as previously described (Ruano et al.,
2000; Gavila´n et al., 2006, 2009). Briefly, proteins from the
cellular fractions were loaded on a 12% or 14% polyacrylamide
gel for electrophoresis (SDS–PAGE; Bio-Rad, Hercules, CA, USA)
and then transferred to a nitrocellulose membrane (Hybond-C
Extra; Amersham, Uppsala, Sweden). After blocking, mem-
branes were incubated overnight at 4 C, with the following pri-
mary antibodies: (i) rabbit polyclonal antibodies against:
ubiquitin (Dako, Glostrup, Denmark) at a dilution of 1 ⁄ 1000;
XBP1 (Abcam, Cambridge, UK), at 1 lg mL)1; ATF6a (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of
1 ⁄ 1500; GRP78 (Santa Cruz Biotechnology) at a dilution of
1 ⁄ 2000; phospho-eIF2a; total eIF2a; phospho-JNK, JNK, Bax,
Bak, Bcl-XL and Bcl-2 (Cell Signaling, Danvers, MA, USA), all of
them at a dilution of 1 ⁄ 1000; CHOP (Santa Cruz Biotechnology)
at a dilution of 1 ⁄ 300; caspase-3 (Stressgen, Ann Arbor, MI,
Table 1 Sequences of the primer pairs used for the real-time PCR
experiments





XBP1 UP GCTTGTGATTGAGAACCAGG 300 20 50
XBP1 LO GAGGCTTGGTGTATACATGG 300 20 50
sXBP1 UP GCTTGTGATTGAGAACCAGG 300 20 50
sXBP1 LO GGCCTGCACCTGCTGCGGACTC 300 22 72.7
ATF6 UP GGACCAGGTGGTGTCAGAG 300 19 63.2
ATF6 LO GACAGCTCTGCGCTTTGG 300 18 61.1
GRP78 UP TCAGCCCACCGTAACAATCAAGG 300 23 43.5
GRP78 LO CTTCCTCAGCAAACTTCTCGGCG 300 23 47.8
PDI UP CTGCTGTTCCTGCCCAAGAGTGT 300 23 56.5




ERP57 LO TGGAGTTAGCTTCTTGTTGGCTG 300 23 47.8
P58IPK UP CAGCCGCTAAAGAAGTCCTC 300 20 55
P58IPK LO GGGTCTTCTCCGTCATCAAA 300 20 50
ACTIN UP CGGAACCGCTCATTGCC 300 17 64.7
ACTIN LO ACCCACACTGTGCCCATCTA 300 20 55
GADD34 UP AGGCTGTGTTCACTCTCTTGC 300 21 52.3
GADD34 LO GCCACATGAGCTACAGCTATCA 300 22 50
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USA) at a dilution of 1 ⁄ 1000; (ii) mouse monoclonal antibody
ATF4 (Abcam) at a dilution of 1 ⁄ 500 and (iii) mouse monoclonal
antibody against b-actin (Sigma-Aldrich) at a dilution of 1 ⁄ 6000.
Then, membranes were incubated with the appropriate second-
ary antibody (Dako), anti-rabbit, anti-goat or anti-mouse horse-
radish-peroxidase-conjugated, at a dilution of 1 ⁄ 6000 and
developed using the ECL-plus detection method (Amersham).
Proteasome activity assay
Proteasome activity was determined using cytosolic fractions
of young and aged saline-injected or lactacystin-treated
animals (6 h postinjection). Chymotrypsin-like activity was
determined using 50 lM of Suc-Leu-Leu-Val-Tyr-aminomethyl-
coumarin (AMC) (Sigma-Aldrich) as substrate. Assay mixtures
containing 10 lg of protein, substrate and 50 mM HEPES-
KOH, pH 7.5, was made up in a final volume of 100 lL. Mea-
sures were performed at 37 C, by monitoring fluorescence
emission (excitation wavelength 380 nm, emission wavelength
460 nm) on a Thermo Scientific Varioskan Flash spectral
scanning multimode reader (software SCANLT, version 2.4.1).
The fluorescence emission was first determined after 2 min of
incubation, and taken each 15 min, during a total incubation
period of 75 min. The product formation was linear during this
time. Triplicate assays were performed for every young and
aged rats (saline, n = 4 ⁄gorup and 6 h postlactacystin injection
n = 4 ⁄ goup). Activity was calculated by comparing the slopes
of the curves obtained by plotting fluorescence vs. time of
incubation, between saline and lactacystin-injected rats. Back-
ground activity was determined by addition of the proteasome
inhibitor MG-132 (Sigma-Aldrich), at a final concentration of
10 lM.
Fluorojade-B staining
Staining with the fluorochrome Fluorojade-B was performed
as a marker of damaged neurons. Young and aged animals
were injected with saline (n = 2 ⁄ group ⁄ time) or lactacystin
(n = 3 ⁄ group ⁄ time) and sacrificed at 24 and 3 days postinjec-
tion. Rats were perfused through the heart under deep anaes-
thesia (chloral hydrate) with 100 mL of PBS containing
10 U mL)1 heparin followed by 150–200 mL of 4% paraform-
aldehyde in phosphate buffer, pH 7.4. Brains were removed and
processed as described (Gavila´n et al., 2007). Briefly, tissue was
mounted on gelatin-coated glass plates and air-dried for 3 days.
Glass plates were placed in a solution containing absolute etha-
nol for 3 min, followed by 70% ethanol solution for 1 min and
rinsed in distilled water for 2 min. The glass plates were then
placed in 0.06% solution of potassium permanganate and agi-
tated for 15 min, before rinsing in distilled water. Finally, the
glass plates were placed in a 0.0005% Fluorojade-B (Sigma-
Aldrich) solution for 30 min and then rinsed in three separate
distilled water baths for 1 min each. Glass plates were air-dried,
placed in a solution containing xylene for 3 min and mounted
for visualization.
Statistical analysis
Data were expressed as mean ± SD. All our data fit significantly
to a normal distribution according to a standardized Kurtosis
test. The data comparison between young and aged groups
and between lactacystin-treated and saline-injected animals
was done by two-tailed t-test. The differences between groups
in the time-course experiments were measured using a
one-way ANOVA followed by Tukey test. The significance was set
at 95% confidence. Significant differences are referenced as
P < 0.05 in the text (* respect to saline-injected animals or, #
respect to young animals). Statistical analysis was done using
the STATGRAPHICS PLUS (v 3.1) program.
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